CompletedPhase 2NCT04544787

A Phase 2 Study to Evaluate the Safety and Immunogenicity of Two Oral Poliovirus Vaccine Candidates

Studying Poliomyelitis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Pierre Van Damme
Principal Investigator
Pierre Van Damme, Prof. MD
Centre for the evaluation of vaccination
Intervention
Novel OPV2 candidate 1(biological)
Enrollment
250 target
Eligibility
18-50 years · All sexes
Timeline
20182019

Study locations (2)

Collaborators

Bill and Melinda Gates Foundation · Centers for Disease Control and Prevention · PATH · Celerion

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04544787 on ClinicalTrials.gov

Other trials for Poliomyelitis

Additional recruiting or active studies for the same condition.

See all trials for Poliomyelitis

← Back to all trials